Cargando…

Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria

BACKGROUND: Atovaquone-proguanil (AP) is the most commonly used treatment for uncomplicated Plasmodium falciparum malaria in the United States. Apparent AP treatment failures were reported 7 months apart in 2 American travelers who stayed in the same compound for foreign workers in Rivers State, Ni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plucinski, Mateusz M., Huber, Curtis S., Akinyi, Sheila, Dalton, Willard, Eschete, Mary, Grady, Katharine, Silva-Flannery, Luciana, Mathison, Blaine A., Udhayakumar, Venkatachalam, Arguin, Paul M., Barnwell, John W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281801/ https://www.ncbi.nlm.nih.gov/pubmed/25734129 http://dx.doi.org/10.1093/ofid/ofu059

Ejemplares similares

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
por: Massamba, Laurencie, et al.
Publicado: (2020)

Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008)

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
por: Wiegmann, Anja, et al.
Publicado: (2022)

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola
por: Pimentel, Sónia, et al.
Publicado: (2006)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
por: Tan, Kathrine R., et al.
Publicado: (2018)

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
por: Skinner-Adams, Tina S., et al.
Publicado: (2019)

In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand
por: Khositnithikul, Rommanee, et al.
Publicado: (2008)

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
por: Sutherland, Colin J, et al.
Publicado: (2008)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
por: Tommasi, Chiara, et al.
Publicado: (2011)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
por: Maude, Richard J, et al.
Publicado: (2014)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
por: Nicosia, V, et al.
Publicado: (2008)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
por: Staines, Henry M, et al.
Publicado: (2018)

Pancytopenia due to proguanil toxicity in a returning traveller with fever
por: Jolink, Hetty, et al.
Publicado: (2010)

Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study
por: Zhang, Naiqi, et al.
Publicado: (2022)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa
por: Happi, Christian T, et al.
Publicado: (2006)

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
por: Wurtz, Nathalie, et al.
Publicado: (2012)

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
por: Laufer, Miriam K., et al.
Publicado: (2012)

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases
por: Cordel, Hugues, et al.
Publicado: (2013)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb
por: Teo, Beatrix Huei-Yi, et al.
Publicado: (2015)

Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine
por: Chalon, Stephan, et al.
Publicado: (2021)

Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum
por: Castañeda-Mogollón, Daniel, et al.
Publicado: (2023)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by Plasmodium relictum in Snowy Owl (Bubo scandiacus)
por: Pugliese, Nicola, et al.
Publicado: (2023)

Severe atovaquone-resistant Plasmodium falciparum malaria in a Canadian traveller returned from the Indian subcontinent
por: Perry, Thomas L, et al.
Publicado: (2009)

Cytauxzoon felis cytochrome b gene mutation associated with atovaquone and azithromycin treatment
por: Hartley, Ashley N., et al.
Publicado: (2020)

Correction: Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign
por: Talundzic, Eldin, et al.
Publicado: (2015)

Selection and Spread of Artemisinin-Resistant Alleles in Thailand Prior to the Global Artemisinin Resistance Containment Campaign
por: Talundzic, Eldin, et al.
Publicado: (2015)

Genetic Characterisation of Plasmodium falciparum Isolates with Deletion of the pfhrp2 and/or pfhrp3 Genes in Colombia: The Amazon Region, a Challenge for Malaria Diagnosis and Control
por: Dorado, Erika Jimena, et al.
Publicado: (2016)

Antimalarial pharmacology and therapeutics of atovaquone
por: Nixon, Gemma L., et al.
Publicado: (2013)

Paludrine (Proguanil) as a Suppressive and Prophylactic in P.-Vivax Infections
por: Desai, V. G.
Publicado: (1951)

Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil
por: Mueller, L., et al.
Publicado: (2017)

Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivax
por: Talundzic, Eldin, et al.
Publicado: (2015)

Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene
por: Afonso, Ana, et al.
Publicado: (2010)

Understanding the Mechanism of Atovaquone Drug Resistance in Plasmodium falciparum Cytochrome b Mutation Y268S Using Computational Methods
por: Akhoon, Bashir A., et al.
Publicado: (2014)

Structural analysis of mitochondrial cytochrome bc(1) complex with atovaquone bound reveals the molecular basis of antimalarial drug action
por: Birth, Dominic, et al.
Publicado: (2014)

Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates
por: van der Velden, Maarten, et al.
Publicado: (2017)

Multiplex malaria antigen detection by bead-based assay and molecular confirmation by PCR shows no evidence of Pfhrp2 and Pfhrp3 deletion in Haiti
por: Herman, Camelia, et al.
Publicado: (2019)

Synergistic augmentation of osimertinib‐induced autophagic death by proguanil or rapamycin in bladder cancer
por: Xiao, Di, et al.
Publicado: (2023)

Deletion of Plasmodium falciparum Histidine-Rich Protein 2 (pfhrp2) and Histidine-Rich Protein 3 (pfhrp3) Genes in Colombian Parasites
por: Murillo Solano, Claribel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pkc0uhp8655didaqtbs2mlgicq